ACE-031 is an ActRIIB-Fc ligand trap used to study myostatin/activin signaling and its role in muscle-growth regulation. The research appeal is straightforward: instead of acting as a growth factor itself, ACE-031 intercepts signals that normally restrain muscle development.

What this formula features: A ligand-trap approach to the myostatin/activin pathway rather than direct stimulation of muscle cells. Published human pharmacology work reported measurable changes in lean mass and thigh muscle volume after a single dose, while biomarker changes also pointed to effects on bone and fat metabolism.

Typical research readouts: Researchers commonly track lean-tissue or muscle-volume changes, myostatin/activin pathway biomarkers, muscle-cell growth signaling, and secondary bone- or fat-metabolism markers. These are research endpoints, not guaranteed outcomes for any individual experiment.

This product is strictly for research purposes only. Not approved for human or animal use.